ProfileGDS4718 / 224845_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 86% 87% 83% 87% 86% 81% 76% 87% 87% 87% 85% 85% 85% 77% 80% 87% 88% 84% 82% 85% 87% 85% 86% 85% 86% 78% 84% 72% 86% 82% 85% 77% 87% 89% 82% 76% 84% 86% 85% 82% 85% 79% 81% 77% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.6819286
GSM549102patient 115, normal, homogenized [OPG study]8.6890787
GSM549104patient 119, normal, homogenized [OPG study]8.2991783
GSM549108patient 138, normal, homogenized [OPG study]8.580887
GSM549119patient 077, normal, homogenized [OPG study]8.5109386
GSM549133patient 032, cancer, homogenized [OPG study]8.0658981
GSM549139patient 042, cancer, homogenized [OPG study]7.4956176
GSM549099patient 107, normal, homogenized [OPG study]8.6273887
GSM549109patient 139, normal, homogenized [OPG study]8.7260287
GSM549110patient 046, normal, homogenized [OPG study]8.715287
GSM549114patient 063, normal, homogenized [OPG study]8.5692785
GSM549122patient 082, normal, homogenized [OPG study]8.5021985
GSM549134patient 033, cancer, homogenized [OPG study]8.5010985
GSM549136patient 036, cancer, homogenized [OPG study]7.6179577
GSM549140patient 044, cancer, homogenized [OPG study]7.923480
GSM549111patient 047, normal, homogenized [OPG study]8.8470187
GSM549113patient 057, normal, homogenized [OPG study]9.0015688
GSM549132patient 031, cancer, homogenized [OPG study]8.3832684
GSM549137patient 038, cancer, homogenized [OPG study]8.1466782
GSM549142patient 047, cancer, homogenized [OPG study]8.1441785
GSM549100patient 110, normal, homogenized [OPG study]8.7607987
GSM549107patient 135, normal, homogenized [OPG study]8.4691685
GSM549115patient 068, normal, homogenized [OPG study]8.8267786
GSM549116patient 072, normal, homogenized [OPG study]8.5196685
GSM549120patient 078, normal, homogenized [OPG study]8.5505786
GSM549131patient 030, cancer, homogenized [OPG study]7.7152978
GSM549118patient 074, normal, homogenized [OPG study]8.414484
GSM549129patient 027, cancer, homogenized [OPG study]7.0923172
GSM549123patient 088, normal, homogenized [OPG study]8.5966586
GSM549124patient 006, cancer, homogenized [OPG study]8.0213282
GSM549126patient 015, cancer, homogenized [OPG study]8.4401585
GSM549128patient 025, cancer, homogenized [OPG study]7.6135377
GSM549103patient 117, normal, homogenized [OPG study]8.5520487
GSM549117patient 073, normal, homogenized [OPG study]9.2545789
GSM549138patient 041, cancer, homogenized [OPG study]8.1034682
GSM549141patient 045, cancer, homogenized [OPG study]7.5460776
GSM549130patient 028, cancer, homogenized [OPG study]8.27784
GSM549101patient 111, normal, homogenized [OPG study]8.5694986
GSM549105patient 128, normal, homogenized [OPG study]8.4350485
GSM549106patient 134, normal, homogenized [OPG study]8.2522882
GSM549112patient 048, normal, homogenized [OPG study]8.5519985
GSM549125patient 011, cancer, homogenized [OPG study]7.7482779
GSM549127patient 024, cancer, homogenized [OPG study]8.0077581
GSM549135patient 035, cancer, homogenized [OPG study]7.6568877